Johnson & Johnson Innovation recently announced their Houston-based venture: JLabs. The incubator will provide business owners and innovators with lab space, private offices, modular laboratory suites and operational, education, and business services. The 34,000-square foot facility can accommodate up to 50 startups. Currently, 21 companies occupy the co-working space, including top tier life science entrepreneurs.
JLABS @ TMC is the fifth JLABS to open in the United States and the first to be equipped with a medical device prototype lab. “We’re thrilled to expand our JLABS initiative into Houston,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman of Pharmaceuticals, Johnson & Johnson. “The city’s rich research, academic, and investment communities provide a robust ecosystem of early stage innovation, and present a unique opportunity to collaborate with Texas startups to deliver much-needed therapeutics, medical devices, and consumer health solutions to patients and consumers more quickly.”
JLABS @ TMC joins a network of facilities throughout the United States the life science field. The incubators are currently home to over 100 early stage companies in the bio/pharmaceutical, medical device, consumer and digital health spaces. Once all six planned JLABS facilities are open, they will have a capacity for 225 companies.
“We have been eagerly awaiting this day when JLABS @ TMC opens its doors and immediately enhances our already robust ecosystem of talented entrepreneurs who are solving the greatest unmet healthcare needs of our generation,” said Robert C. Robbins, M.D., President and CEO of the Texas Medical Center. “TMC has spent decades making healthcare history, and now these business accelerators housed at TMC will take innovation to new heights.”
